| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.8M | +6.7% | +57.7% |
| Cost of Revenue | $2.8M | +6.7% | +59.4% |
| Gross Profit | $9.0M | +6.8% | +57.2% |
| R&D Expense | $1.5M | +8.5% | +39.9% |
| SG&A Expense | $15.1M | +17.3% | +77.5% |
| Operating Income | -$7.6M | -30.3% | -96.9% |
| Pre-tax Income | -$8.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.9M | +103.1% | — |
| Accounts Receivable | $7.1M | +2.8% | — |
| Inventory | $19.4M | +13.3% | — |
| Current Assets | $166.6M | +141.8% | — |
| Total Assets | $177.8M | +128.4% | — |
| Current Liabilities | $15.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.8M | — | — |
| Capital Expenditures | $5.1M | — | — |
| Investing Cash Flow | -$78.3M | — | — |
| Financing Cash Flow | $147.0M | — | — |
| Free Cash Flow | -$25.0M | — | — |
| +54.5% |
| -115.3% |
| Income Tax | $0 | — | — |
| Net Income | -$8.7M | +54.5% | -115.3% |
| EPS (Basic) | -$0.64 | +99.6% | +99.1% |
| EPS (Diluted) | -$0.64 | +99.6% | +99.1% |
| +20.2% |
| — |
| Long-term Debt | $14.8M | +0.4% | — |
| Total Liabilities | $29.9M | +2.0% | — |
| Stockholders' Equity | $147.8M | +289.0% | +390.6% |